Franz Porzolt graduated from the University of Marburg School of Medicine and completed a postdoctoral fellowship on a grant from the Deutsche Forschungs-Gemeinschaft at the Princess-Margaret Hospital and Ontario Cancer Institute in Toronto. He received training in Internal Medicine, Hematology, and Medical Oncology at the Medical School of the University of Ulm, where he performed laboratory work and completed his doctoral thesis on "Natural Killer Cells." He established the Clinical Economics Group, which is involved in developing tools for assessing the (non- monetary) values of medical interventions from the patient's point of view. In 2000 he received a second appointment at the Ludwig-Maximilian University in Munich and a teaching contract with the Technical University in Munich to integrate Evidence-Based Medicine into the curriculum of medical students. He has worked with the Cochrane Collaboration, and currently has a contract to offer evidence based medicine training in the Alto Adige (Italy). Robert M. Kaplan is Professor and Chair of the Department of Health Services and Professor of Medicine at UCLA. From 1997-2004, he was Professor and Chair of the Department of Family and Preventive Medicine at the University of California, San Diego. He is currently Chair-Elect of the Behavioral Science Council of the American Thoracic Society. Dr. Kaplan is the Editor- in-Chief of the Annals of Behavioral Medicine and Consulting Editor of four other academic journals. He is currently Co-Chairman of the Behavioral Committee for the NIH Women 's Health Initiative and a member of both the NHLBI Behavioral Medicine Task Force and the Institute of Medicine (IOM) National Academy of Sciences Committee on Health and Behavior. In addition, he is the Chairman of the Cost Effectiveness Committee for the NHLBI National Emphysema Treatment Trial (NETT).

• Framework of CLINECS.- “CLINECS”: Strategy and Tactics to Provide Evidence of the Usefulness of Health Care Services from the Patient's Perspective (Value for Patients).- Systems View of Health Care.- Ethics and Philosophy.- Seeking Justice in Health Care.- Evidence-Based Medicine and Ethics: Desired and Undesired Effects of Screening.- Paradoxes of Medical Progress: Abandoned Patients, Physicians, and Nurses.- Theory Behind the Bridge Principles.- Psychology.- How to Measure Quality of Life.- New Instrument to Describe Indicators of Well-Being in Old Old Patients with Severe Dementia: Vienna List.- Patient Empowerment: Increased Compliance or Total Transformation?.- Shared Decision Making in Medicine.- Clinical Practice.- Overdiagnosis and Pseudodisease: Too Much of a “Good Thing”?.- Palliative Medicine Today: Evidence and Culture.- Medical Geography–Who Gets the Goods? More May Not Be Better.- Cancer Survival in Europe and the United States.- Patient Safety: What Does It Mean in the United States?.- Increasing Safety by Implementing Optimized Team Interaction: Experience from the Aviation Industry.- Evidence-Based Information Technology: Concept for Rational Information Processing in the Health Care System.- Economically Oriented Analyses.- Cost-Effectiveness Analysis: Measuring the Value of Health Care Services.- Cost-Effectiveness of Lung Volume Reduction Surgery.- Health Economic Evaluation of Adjuvant Breast Cancer Treatment.- Aims and Value of Screening: Is Perceived Safety a Value for Which to Pay?.- Clinical Epidemiology.- Evidence-Based Health Care Seen From Four Points of View.- Efficacy, Effectiveness, and Efficiency of Diagnostic Technology.- Reduced Mammographic Screening May Explain Declines in Breast Carcinoma Among Older Women.- “Fading ofReported Effectiveness” Bias: Longitudinal Meta-Analysis of Randomized Controlled Trials.- Clinical Research and Outcomes Research: Common Criteria and Differences.- Are the Results of Randomized Trials Influenced by Preference Effects? Part I. Findings from a Systematic Review.- Are the Results of Randomized Trials Influenced by Preference Effects? Part II. Why Current Studies Often Fail to Answer this Question.- Conclusion and Outlook.- Suggested Changes in Practice, Research, and Systems: Clinical Economics Point of View.

Franz Porzolt graduated from the University of Marburg School of Medicine and completed a postdoctoral fellowship on a grant from the Deutsche Forschungs-Gemeinschaft at the Princess-Margaret Hospital and Ontario Cancer Institute in Toronto. He received training in Internal Medicine, Hematology, and Medical Oncology at the Medical School of the University of Ulm, where he performed laboratory work and completed his doctoral thesis on "Natural Killer Cells." He established the Clinical Economics Group, which is involved in developing tools for assessing the (non- monetary) values of medical interventions from the patient's point of view. In 2000 he received a second appointment at the Ludwig-Maximilian University in Munich and a teaching contract with the Technical University in Munich to integrate Evidence-Based Medicine into the curriculum of medical students. He has worked with the Cochrane Collaboration, and currently has a contract to offer evidence based medicine training in the Alto Adige (Italy). Robert M. Kaplan is Professor and Chair of the Department of Health Services and Professor of Medicine at UCLA. From 1997-2004, he was Professor and Chair of the Department of Family and Preventive Medicine at the University of California, San Diego. He is currently Chair-Elect of the Behavioral Science Council of the American Thoracic Society. Dr. Kaplan is the Editor- in-Chief of the Annals of Behavioral Medicine and Consulting Editor of four other academic journals. He is currently Co-Chairman of the Behavioral Committee for the NIH Women 's Health Initiative and a member of both the NHLBI Behavioral Medicine Task Force and the Institute of Medicine (IOM) National Academy of Sciences Committee on Health and Behavior. In addition, he is the Chairman of the Cost Effectiveness Committee for the NHLBI National Emphysema Treatment Trial (NETT).

• Framework of CLINECS.- “CLINECS”: Strategy and Tactics to Provide Evidence of the Usefulness of Health Care Services from the Patient's Perspective (Value for Patients).- Systems View of Health Care.- Ethics and Philosophy.- Seeking Justice in Health Care.- Evidence-Based Medicine and Ethics: Desired and Undesired Effects of Screening.- Paradoxes of Medical Progress: Abandoned Patients, Physicians, and Nurses.- Theory Behind the Bridge Principles.- Psychology.- How to Measure Quality of Life.- New Instrument to Describe Indicators of Well-Being in Old Old Patients with Severe Dementia: Vienna List.- Patient Empowerment: Increased Compliance or Total Transformation?.- Shared Decision Making in Medicine.- Clinical Practice.- Overdiagnosis and Pseudodisease: Too Much of a “Good Thing”?.- Palliative Medicine Today: Evidence and Culture.- Medical Geography–Who Gets the Goods? More May Not Be Better.- Cancer Survival in Europe and the United States.- Patient Safety: What Does It Mean in the United States?.- Increasing Safety by Implementing Optimized Team Interaction: Experience from the Aviation Industry.- Evidence-Based Information Technology: Concept for Rational Information Processing in the Health Care System.- Economically Oriented Analyses.- Cost-Effectiveness Analysis: Measuring the Value of Health Care Services.- Cost-Effectiveness of Lung Volume Reduction Surgery.- Health Economic Evaluation of Adjuvant Breast Cancer Treatment.- Aims and Value of Screening: Is Perceived Safety a Value for Which to Pay?.- Clinical Epidemiology.- Evidence-Based Health Care Seen From Four Points of View.- Efficacy, Effectiveness, and Efficiency of Diagnostic Technology.- Reduced Mammographic Screening May Explain Declines in Breast Carcinoma Among Older Women.- “Fading ofReported Effectiveness” Bias: Longitudinal Meta-Analysis of Randomized Controlled Trials.- Clinical Research and Outcomes Research: Common Criteria and Differences.- Are the Results of Randomized Trials Influenced by Preference Effects? Part I. Findings from a Systematic Review.- Are the Results of Randomized Trials Influenced by Preference Effects? Part II. Why Current Studies Often Fail to Answer this Question.- Conclusion and Outlook.- Suggested Changes in Practice, Research, and Systems: Clinical Economics Point of View.

Franz Porzolt graduated from the University of Marburg School of Medicine and completed a postdoctoral fellowship on a grant from the Deutsche Forschungs-Gemeinschaft at the Princess-Margaret Hospital and Ontario Cancer Institute in Toronto. He received training in Internal Medicine, Hematology, and Medical Oncology at the Medical School of the University of Ulm, where he performed laboratory work and completed his doctoral thesis on "Natural Killer Cells." He established the Clinical Economics Group, which is involved in developing tools for assessing the (non- monetary) values of medical interventions from the patient's point of view. In 2000 he received a second appointment at the Ludwig-Maximilian University in Munich and a teaching contract with the Technical University in Munich to integrate Evidence-Based Medicine into the curriculum of medical students. He has worked with the Cochrane Collaboration, and currently has a contract to offer evidence based medicine training in the Alto Adige (Italy). Robert M. Kaplan is Professor and Chair of the Department of Health Services and Professor of Medicine at UCLA. From 1997-2004, he was Professor and Chair of the Department of Family and Preventive Medicine at the University of California, San Diego. He is currently Chair-Elect of the Behavioral Science Council of the American Thoracic Society. Dr. Kaplan is the Editor- in-Chief of the Annals of Behavioral Medicine and Consulting Editor of four other academic journals. He is currently Co-Chairman of the Behavioral Committee for the NIH Women 's Health Initiative and a member of both the NHLBI Behavioral Medicine Task Force and the Institute of Medicine (IOM) National Academy of Sciences Committee on Health and Behavior. In addition, he is the Chairman of the Cost Effectiveness Committee for the NHLBI National Emphysema Treatment Trial (NETT).

• Framework of CLINECS.- “CLINECS”: Strategy and Tactics to Provide Evidence of the Usefulness of Health Care Services from the Patient's Perspective (Value for Patients).- Systems View of Health Care.- Ethics and Philosophy.- Seeking Justice in Health Care.- Evidence-Based Medicine and Ethics: Desired and Undesired Effects of Screening.- Paradoxes of Medical Progress: Abandoned Patients, Physicians, and Nurses.- Theory Behind the Bridge Principles.- Psychology.- How to Measure Quality of Life.- New Instrument to Describe Indicators of Well-Being in Old Old Patients with Severe Dementia: Vienna List.- Patient Empowerment: Increased Compliance or Total Transformation?.- Shared Decision Making in Medicine.- Clinical Practice.- Overdiagnosis and Pseudodisease: Too Much of a “Good Thing”?.- Palliative Medicine Today: Evidence and Culture.- Medical Geography–Who Gets the Goods? More May Not Be Better.- Cancer Survival in Europe and the United States.- Patient Safety: What Does It Mean in the United States?.- Increasing Safety by Implementing Optimized Team Interaction: Experience from the Aviation Industry.- Evidence-Based Information Technology: Concept for Rational Information Processing in the Health Care System.- Economically Oriented Analyses.- Cost-Effectiveness Analysis: Measuring the Value of Health Care Services.- Cost-Effectiveness of Lung Volume Reduction Surgery.- Health Economic Evaluation of Adjuvant Breast Cancer Treatment.- Aims and Value of Screening: Is Perceived Safety a Value for Which to Pay?.- Clinical Epidemiology.- Evidence-Based Health Care Seen From Four Points of View.- Efficacy, Effectiveness, and Efficiency of Diagnostic Technology.- Reduced Mammographic Screening May Explain Declines in Breast Carcinoma Among Older Women.- “Fading ofReported Effectiveness” Bias: Longitudinal Meta-Analysis of Randomized Controlled Trials.- Clinical Research and Outcomes Research: Common Criteria and Differences.- Are the Results of Randomized Trials Influenced by Preference Effects? Part I. Findings from a Systematic Review.- Are the Results of Randomized Trials Influenced by Preference Effects? Part II. Why Current Studies Often Fail to Answer this Question.- Conclusion and Outlook.- Suggested Changes in Practice, Research, and Systems: Clinical Economics Point of View.